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Previewsextrasynaptic NMDA receptors has bene-
ficial outcomes. Although these studies
represent an important contribution to
the understanding of the pathophysiology
of HD, this disease involves multiple
organs, multiple brain regions and
changes in numerous neurotransmitter
and receptor systems. It is probable that
combination drug therapies, accounting
for the multiple brain areas affected, the
different ways they are affected, and the
progression of the symptoms of HD, will
provide the most efficacious approach
to treatments.
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Hypothalamic dopamine neurons inhibit pituitary prolactin secretion. In this issue of Neuron, Lyons et al.
provide evidence for a novel model, whereby the excitatory neuropeptide TRH depolarizes gap-junction-
coupled dopamine neurons, leading to a shift in the population pattern of action potentials from phasic burst
firing to regular tonic firing, hypothetically reducing dopamine release while increasing total spike number.Prolactin is a fascinating pituitary hor-
mone that promotes milk synthesis during
lactation; its chemical structure is similar
to that of growth hormone. Prolactin
also enhances maternal behavior, and
paternal behavior in some species, modu-
lates immune responses, and is luteotro-
phic. Prolactin has also been associated
with reduced fertility during lactation,
thereby enhancing the direction of mater-
nal energy stores toward a new infant
rather than toward pregnancy (Freeman
et al., 2000). Most of the functions of
prolactin, including lactation, are carried
out in concert with other hormones
that collaborate to achieve a functional
response.Hypothalamic peptides released by
axons in the median eminence regulate
hormones synthesized and released by
the anterior pituitary, or adenohypoph-
ysis. In contrast to other pituitary hor-
mones that are controlled by releasing
factors, secretion of prolactin is controlled
by an inhibiting factor, dopamine. Dopa-
mine is synthesized by a subset of
neurons in the hypothalamic arcuate
nucleus, sometimes called tuberoinfun-
dibular dopamine (TIDA) neurons, that
release the monoamine from axon termi-
nals in the median eminence. Dopamine
is then carried by the portal blood system
to the pituitary where it activates dopa-
mine G protein coupled D2 receptorsthat reduce cAMP and attenuate pro-
lactin release, synthesis, and division of
prolactin cells. The current model of
CNS control of prolactin secretion is
based on the view that when dopamine
neurons in the arcuate nucleus stop
firing, this leads to a loss of dopamine-
mediated inhibition of the prolactin-
secreting cells, thereby increasing pro-
lactin release.
In a new paper in Neuron, Lyons, Hor-
jales-Araujo, and Broberger (Lyons et al.,
2010) from the Karolinska Institute in
Sweden record from hypothalamic slices,
and demonstrate for the first time that
arcuate dopamine neurons show phasic
bursts of spikes (20 spikes over 4–5 s), January 28, 2010 ª2010 Elsevier Inc. 147
Neuron
Previewsoccurring at 20 s intervals. These oscil-
lator neurons show slow 30 mV depolar-
izations in membrane potential, with
the spike burst occurring at the most
depolarized state, followed by rapid
hyperpolarization, and then a new cycle
of depolarization. Current-voltage anal-
ysis revealed two characteristic conduc-
tances, anomalous inward rectification
and a large A-like transient outward
rectification, with no apparent Ih current
typical ofmany other pacemaker neurons.
That these cells project to the median
eminence was confirmed by recording
cells labeled by intravenous Evans Blue
dye injection.
Interestingly, spike bursts in different
dopamine neurons are temporally cou-
pled. Surprisingly, this coupling was not
affected by blockade of synaptic commu-
nication, but instead appeared to be
based on a mechanism of gap-junction-
mediated communication between neu-
rons. Gap junction blockers carbenoxo-
lone or glycyrrhetinic acid attenuated the
temporal coupling. In the process of
identifying the cells by dye-filling followed
by immunocytochemistry, the dendritic
architecture of the dopamine neurons
was revealed. Unlike other arcuate
nucleus neurons that have simple, often
bipolar dendritic arbors, dopamine
neurons had four to five primary dendrites
arising from the cell body. Gap junction
morphology, size, type, and frequency in
TIDA neurons are unknown. However,
ultrastructural studies of TIDA neurons
found unusual, selective, and frequent
apposition between two dopamine den-
drites, or between a dendrite and cell
body (Piotte et al., 1985). Although gap
junctions were not described, these
extensive regions of membrane apposi-
tion between dopamine neurons would
be the most likely site for gap junctions.
Small or infrequent gap junctions between
neurons may allow some synchronization
over minutes to hours, but the fast burst
synchronization here is likely mediated
by larger and more frequent gap junctions
(Rash et al., 2007).
Asmany dopamine cells are coupled by
the electrotonic junctions, one could
imagine a model by which depolarizing
current could flow additively frommultiple
cells during slow depolarization, resulting
in maximized synchrony of spike bursts.
Furthermore, strong gap junction cou-148 Neuron 65, January 28, 2010 ª2010 Elsepling of multiple cells may enhance depo-
larization of cells that might otherwise
show modest depolarization, and thereby
may enhance or initiate bursting in indi-
vidual cells that alone might not burst.
Electrotonic coupling in a neuronal popu-
lation leads to complex network proper-
ties whereby the population tends to
show all-or-none network bursts; a weak
or diffuse input is shunted throughout
the network, whereas a synchronous
excitatory input generates (in an all-or-
none manner) network bursts.
The underlying assumption on which
the Lyons paper rests is that bursting
increases dopamine release to a much
greater level than tonic firing. If this
assumption is correct, the maximal
concentration of dopamine in the portal
blood supply is further enhanced by
the gap-junction-mediated synchronous
release of many, perhaps most, of the
arcuate dopamine neurons. However,
a 4–5 s dopamine release into the median
eminence at 20 s intervals will probably
not activate receptors in the same square
wave pattern, given the dilution by the
blood and varying distances to prolactin
cells in the pituitary. The temporal pattern
of dopamine arriving in the pituitary at
prolactin cells merits study to determine
the functional role of the short-period
pulsatile release of dopamine in its activa-
tion of the D2 receptors; it is possible that
the critical factor here is not the period-
icity of receptor activation, but rather
that the periodicity of firing maximizes
dopamine release.
Thyrotropin-releasing hormone (TRH),
the primary hypothalamic neuropeptide
that evokes thyroid-stimulating hormone
(TSH) release from the pituitary, has also
been shown to enhance prolactin release.
Since prolactin cells can respond directly
to TRH, it has been assumed that TRH
acts directly in the pituitary. However,
Lyons et al. show that TRH axonal
boutons surround arcuate dopamine
neurons, and TRH application depolarizes
the dopamine neurons, causing them to
shift from a phasic bursting pattern to
a regular 1.6 Hz tonic pattern. Lyons
et al. point out that the spike frequency
during the burst (4 Hz) is substantially
greater than the tonic firing rate. However,
over time, the total number of spikes
recorded during tonic firing (32 spikes/
20 s) is actually greater than the meanvier Inc.spike frequency associated with bursting
behavior (20 spikes/20 s). Based on pre-
vious work measuring oxytocin or vaso-
pressin release from the neurohypoph-
ysis, dense-core vesicle secretion is
greater per spike in bursts than with
regular firing. In parallel, studies of the
substantia nigra dopamine neurons find
burst firing substantially enhances dopa-
mine release, and gap junctions between
nigral dopamine neurons occur, but may
not be as frequent as in the arcuate
nucleus (Overton and Clark, 1997). The
working assumption is that TRH, in its
depolarizing initiation of tonic firing
in TIDA neurons, substantially reduces
dopamine release. But as dopamine
release was not measured, this remains
a missing piece of the puzzle that will
profit from experimental confirmation.
Unresolved questions remain. The
experiments of Lyons et al. were done
on immature rats; since release of pro-
lactin is principally important in adult
mothers, it would be nice to confirm the
data with mature female rats. In addition,
gap junctions are more common in
the immature brain, and therefore corrob-
oration of these results in adults will
strengthen the model.
Release characteristics of the fast
transmitters glutamate and GABA have
been studied in great detail, and the
wealth of information available benefits
chiefly from our ability to investigate
release by studying the easily detected
electrophysiological response of postsyn-
aptic cells milliseconds later. In contrast,
neuromodulators such as dopamine and
most neuropeptides activate G protein
coupled receptors that show responses
in a substantially slower time frame,
making it much more difficult to study
release by measuring response. Micro-
dialysis, collecting portal blood, or mea-
suring neuromodulators in peripheral
blood is done on a timescale of minutes
to hours. Alternately, imaging of exocy-
totic vesicles can be done with agents
such as FM1-43, pH-sensitive dyes,
or engineered proteins (Gaffield and
Betz,2006; Zhu et al., 2009), but at best
this gives information about vesicular
fusion and exocytosis, which may be diffi-
cult to correlate with neuromodulator
release. One promising approach to mea-
suring release from dense-core vesicles
is the use of expressed recombinant
Neuron
Previewsgenes coding for the neuropeptide FMRF
and the invertebrate FMRF receptor that
gates ion channels, and therefore allows
millisecond time resolution in detecting
neuropeptide release (Whim and Moss,
2001).
Many if not most neurons contain both
fast transmitters such as glutamate and
GABA that are released presynaptically,
in addition to neuromodulators including
dopamine or TRH that are released by
axonal boutons, but not necessarily at
the synaptic specialization. In the hypo-
thalamus, ultrastructural serial section
analysis showed that most axonal bou-
tons have two types of vesicle, the small
clear vesicles congregated at the synaptic
junction, and dense-core vesicles that are
found farther away from the synaptic
specialization (Decavel and van den Pol,
1990). Based on immunostaining of
catecholamines and vesicular monamine
transporters, dopamine has been sug-
gested to be localized in both types of
vesicle (Liu et al., 1994; Nirenberg
et al.,1995; Henry et al., 1998). Although
hundreds of papers have examined the
behavioral or physiological response to
injection of neuropeptides and amines
into the brain, the actual release of these
agents from axon terminals, particularly
from dense-core vesicles, is an area that
merits more attention. We know relatively
little about the release characteristics of
most monoamines and neuropeptides
from axons within the brain. Much of
what we know arises from work done on
release of oxytocin and vasopressin
from the posterior pituitary, as mentioned
above. The posterior pituitary presents
a good model of peptide release because
of the large number of axons that release
measurable levels of peptide (Dutton and
Dyball, 1977; Dreifuss et al., 1971). But
neuropeptide release in the brain is
substantively different than that in the
posterior pituitary; brain neuropeptides
are localized in smaller dense-core gran-
ules that are much less abundant thanthose in the neurohypophysis. And where
amino acid transmitters and dopamine
can be synthesized and transported into
vesicles locally in axonal boutons, neuro-
peptides are made in the cell body, and
peptide synthesis and transport of the
dense-core vesicles to axon terminals
may take several hours.
Although TRH is shown to depolarize
the membrane potential of arcuate dopa-
mine neurons, the question remains as to
whether this is the primary transmitter
controlling TIDA neurons to evoke release
of prolactin. Injections of TRH can lead to
prolactin release, in part by a direct action
on pituitary prolactin cells; however, the
temporal release of TRH and TSH in
animals does not show a high correlation
with prolactin release (Freeman et al.,
2000); furthermore, since TRH is the
primary agent regulating TSH release, it
would seem unlikely that two pituitary
hormones with strikingly different func-
tions would be regulated by a single
releasing factor. One possibility is that
different TRH neurons release peptide
into the median eminence and onto
arcuate nucleus neurons. TRH cells are
found in the arcuate, paraventricular, dor-
somedial, and lateral hypothalamic nuclei,
and other areas of the brain. An alternate
possibility is that other transmitters and
modulators may also depolarize dopa-
mine neurons and could therefore cause
the same resultant shift to tonic firing. In
addition to glutamate acting at either ion-
otropic or metabotropic receptors,
a number of neuropeptides, including hy-
pocretin, GLP-1, neuromedin B, gastrin
releasing peptide, and additional neuro-
modulators, excite other neurons of the
arcuate nucleus (Acuna-Goycolea and
van den Pol, 2009), and may therefore
also activate the TIDA cells.
These novel data in Lyon’s paper open
the door on a new perspective of hypo-
thalamic regulation of prolactin release.
Rather than the inhibitory dopamine
neurons changing from an active state toNeuron 65a silent state, induced by either GABA or
one of the many inhibitory modulators of
the arcuate nucleus, the new model here
posits that a reduction in dopamine
release instead is evoked by an excitatory
neuromodulator that depolarizes the
membrane potential and increases the
general spike frequency over time, but
attenuates the critical phasic bursting of
the dopamine cells, thereby reducing
dopamine releaseand increasingprolactin
secretion.
REFERENCES
Acuna-Goycolea, C., and van den Pol, A.N. (2009).
J. Neurosci. 29, 1503–1515.
Decavel, C., and van den Pol, A.N. (1990). J. Comp.
Neurol. 302, 1019–1037.
Dreifuss, J.J., Kalnins, I., Kelly, J.S., and Ruf, K.
(1971). J. Physiol. 215, 805–817.
Dutton, A., and Dyball, R.E.J. (1977). J. Physiol.
290, 433–440.
Freeman, M.E., Kanyicska, B., Lerant, A., and
Nagy, G. (2000). Physiol. Rev. 80, 1523–1631.
Gaffield, M.A., and Betz, W.J. (2006). Nat. Protoc.
1, 2916–2921.
Henry, J.P., Sagne´, C., Bedet, C., and Gasnier, B.
(1998). Neurochem. Int. 32, 227–246.
Liu, Y., Schweitzer, E.S., Nirenberg, M.J., Pickel,
V.M., Evans, C.J., and Edwards, R.H. (1994).
J. Cell Biol. 127, 1419–1433.
Lyons, D.J., Horjales-Araujo, E., and Broberger, C.
(2010). Neuron 65, this issue, 217–229.
Nirenberg, M.J., Liu, Y., Peter, D., Edwards, R.H.,
and Pickel, V.M. (1995). Proc. Natl. Acad. Sci.
USA 92, 8773–8777.
Overton, P.G., and Clark, D. (1997). Brain Res.
Brain Res. Rev. 25, 312–334.
Piotte, M., Beaudet, A., Joh, T.H., and Brawer, J.R.
(1985). J. Comp. Neurol. 239, 44–53.
Rash, J.E., Olson, C.O., Pouliot, W.A., Davidson,
K.G.V., Yasumura, T., Furman, C.S., Royer, S.,
Kamasawa, N., Nagy, J.I., and Dudek, F.E.
(2007). Neuroscience 149, 350–371.
Whim, M.D., and Moss, G.W. (2001). Neuron 30,
37–50.
Zhu, Y., Xu, J., and Heinemann, S.F. (2009).
Neuron 61, 397–411., January 28, 2010 ª2010 Elsevier Inc. 149
